Harriss Currie was named Chief Financial Officer of AdaptHealth Corp., effective September 9, 2026. As of November 6, 2026, AdaptHealth Corp. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 5, 2026 to September 8, 2026, naming 2 appointments (Form 8-K, September 8, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like AdaptHealth Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: Harriss Currie · Role: Chief Financial Officer · Effective: 2026-09-09 · 8-K, 2026-09-08
- · In / out: Reported · Person: not named in the filing · 8-K/A, 2026-06-02
- · In / out: In · Person: Daniel McFadden · Role: Chief Operating Officer · 8-K, 2026-05-05
AdaptHealth Corp. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-05 to 2026-09-08. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as AdaptHealth Corp. files it.
Also on the record for AdaptHealth Corp.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 7.9% of the class | 5%+ stakes | Source |
| October 13, 2026 | Stake report, Schedule 13G/A, by REINHART PARTNERS, LLC. | — | 5%+ stakes | Source |
| October 8, 2026 | Stake report, Schedule 13G/A, by Dimensional Fund Advisors LP | 4.7% of the class | 5%+ stakes | Source |
| April 9, 2026 | Stake report, Schedule 13G, by Dimensional Fund Advisors LP | 5.1% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 12, 2026 | Stake report, Schedule 13D/A, by Richard Cashin | 11.7% of the class | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 5.6% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Deerfield Management Company, L.P. | 8.48% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 8.33% of the class | 5%+ stakes | Source |
| August 6, 2025 | Stake report, Schedule 13G, by FMR LLC | 6.7% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 10.9% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs AdaptHealth Corp. now and the warning signs.
Free to see. No signup.
Keep reading
More on AdaptHealth Corp. and the records around it.
AdaptHealth Corp. elsewhere on the record
Companies that share a holder
- REINHART PARTNERS, LLC. also filed stake reports on 7 other companies: YETI Holdings, Inc. (Oct 2026)
- Deerfield Mgmt, L.P. also filed stake reports on 19 other companies: Climb Bio, Inc. (Oct 2026), Cogent Biosciences, Inc. (Aug 2026), Enhabit, Inc. (Aug 2026)
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
Watch AdaptHealth Corp.
Get an email when AdaptHealth Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on AdaptHealth Corp.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on AdaptHealth Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AdaptHealth Corp. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-08 | In | Chief Financial Officer | 2026-09-09 | 8-K, 2026-09-08 | |
| 2026-06-02 | Reported | not named in the filing | 8-K/A, 2026-06-02 | ||
| 2026-05-05 | In | Chief Operating Officer | 8-K, 2026-05-05 |
Who leads AdaptHealth Corp., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Harriss Currie, appointed, effective 2026-09-09 (filed 2026-09-08).
- Chief Operating Officer: Daniel McFadden, appointed (filed 2026-05-05).
New leaders reset buying decisions — get the Full Report on AdaptHealth Corp.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at AdaptHealth Corp., with the record behind each one.
Find candidates like Chief Financial Officer at AdaptHealth Corp.Every change, in the filing's words
Appointed: Harriss Currie, Chief Financial Officer, effective 2026-09-09
Chief Financial Officer Appointment AdaptHealth Corp. (the "Company") announced today that Harriss Currie, age 64, has been appointed to serve as the Chief Financial Officer of the Company, effective as of September 9, 2026 (the "Start Date").
- Mr. Currie served as Chief Financial Officer at Health Track RX, a developer of an infectious disease diagnostics platform, from December 2025 to May 2026.
- Previously, he served as President of the Regenerative Medicine Division of 3D Systems, a developer of high-resolution 3D bioprinting technologies, from December 2023 to July 2025.
- Before that, Mr. Currie served as Chief Financial Officer at Impulse Dynamics, a medical device company that develops treatments for chronic heart failure, from January 2022 to July 2023, and as Chief Financial Officer of Luminex Corp., a developer, manufacturer, and marketer of proprietary biological testing technologies and diagnostic tools for clinical laboratories and researchers, from October 2003 until its sale to DiaSorin in July 2021.
- Mr. Currie holds an MBA from the McCombs School of Business at the University of Texas at Austin and previously served as an audit manager at Deloitte & Touche.
- Pursuant to the terms of the Currie Employment Agreement, Mr. Currie is entitled to receive an annual base salary of $670,000 and is eligible to receive a target annual incentive bonus equal to 100% of his base salary, with the actual bonus based on the achievement of annual performance objectives for such fiscal year.
Reported
On May 5, 2026, AdaptHealth Corp. (the "Company") filed a Current Report on Form 8-K (the "Original Filing") reporting, among other things, the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026 (the "Appointment Date").
- The Original Filing inadvertently reported the Date of Report (Date of earliest event reported) on the cover page as May 5, 2026, when it should have been reported as May 4, 2026.
- This Amendment No. 1 supplements the Original Filing and should be read in conjunction with the Original Filing.
- On May 27, 2026, in connection with Mr. McFadden's promotion to Chief Operating Officer, the Compensation Committee of the Company's Board of Directors (the "Committee") approved an increase to Mr. McFadden's annual base salary from $410,000 to $550,000, with retroactive effect to the Appointment Date.
- Mr. McFadden will continue to be eligible to receive an annual incentive bonus with a target amount equal to 100% of his increased base salary.
- For the Company's 2026 fiscal year, such target bonus amount and any actual bonus payable will be pro-rated based on the actual base salary paid to Mr. McFadden in 2026.
- Except as expressly stated herein, this Amendment No. 1 does not amend or update any other information contained in the Original Filing, which remains unchanged.
Appointed: Daniel McFadden, Chief Operating Officer
Also on May 4, 2026, the Company appointed Daniel McFadden, the Company's current Chief Business Systems Officer, as the Company's Chief Operating Officer.
- - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers.
- On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company's Chief Operating Officer.
- Mr. Barnhart will receive severance and other benefits available for a termination by the Company without Cause (as defined in Mr. Barnhart's employment agreement), in accordance with the terms of such employment agreement, which such terms were disclosed in the Company's proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 28, 2026 (the "2026 Proxy Statement").
- Biographical and other information about Mr. McFadden is set forth in the 2026 Proxy Statement.
Tools for this story
Each opens in a new tab, filled in for AdaptHealth Corp.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.